Display options
Cite
Sakamoto R, Ohtake Y, Kataoka Y, et al. Efficacy of acceptance and commitment therapy for people with type 2 diabetes: Systematic review and meta-analysis. J Diabetes Investig. 2021;doi: 10.1111/jdi.13658.
Sakamoto, R., Ohtake, Y., Kataoka, Y., Matsuda, Y., Hata, T., Otonari, J., Yamane, A., Matsuoka, H., & Yoshiuchi, K. (2021). Efficacy of acceptance and commitment therapy for people with type 2 diabetes: Systematic review and meta-analysis. Journal of diabetes investigation, . https://doi.org/10.1111/jdi.13658
Sakamoto, Ryo, et al. "Efficacy of acceptance and commitment therapy for people with type 2 diabetes: Systematic review and meta-analysis." Journal of diabetes investigation vol. (2021). doi: https://doi.org/10.1111/jdi.13658
Sakamoto R, Ohtake Y, Kataoka Y, Matsuda Y, Hata T, Otonari J, Yamane A, Matsuoka H, Yoshiuchi K. Efficacy of acceptance and commitment therapy for people with type 2 diabetes: Systematic review and meta-analysis. J Diabetes Investig. 2021 Sep 06; doi: 10.1111/jdi.13658. Epub 2021 Sep 06. PMID: 34486816.
Copy Download .nbib Format: NLM
Share it on

J Diabetes Investig. 2021 Sep 06; doi: 10.1111/jdi.13658. Epub 2021 Sep 06.

Efficacy of acceptance and commitment therapy for people with type 2 diabetes: Systematic review and meta-analysis.

Journal of diabetes investigation

Ryo Sakamoto, Yoichi Ohtake, Yuki Kataoka, Yoshinobu Matsuda, Tomokazu Hata, Jun Otonari, Akira Yamane, Hiromichi Matsuoka, Kazuhiro Yoshiuchi

Affiliations

  1. Department of Psychosomatic Medicine, Faculty of Medicine, Kindai University, Osakasayama, Japan.
  2. Department of Internal Medicine, Itami Seifu Houpital, Itami, Japan.
  3. Department of Psychosomatic Internal Medicine a Palliative Care Medicine, Sakai City Medical Center, Sakai, Japan.
  4. Department of Internal Medicine, Kyoto Min-Iren Asukai Hospital, Kyoto, Japan.
  5. Systematic Review Workshop Peer Support Group (SRWS-PSG), Osaka, Japan.
  6. Section of Clinical Epidemiology, Department of Community Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  7. Department of Healthcare Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
  8. Department of Psychosomatic Internal Medicine, National Hospital Organisation Kinki-Chuo Chest Medical Center, Sakai, Japan.
  9. Department of Psychosomatic Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  10. Department of Psychosomatic Medicine, International University of Health and Welfare Narita Hospital, Chiba, Japan.
  11. Department of Psychosomatic Medicine, Kansai Medical University Hospital, Hirakata, Japan.
  12. Department of Psych-oncology, National Cancer Center Hospital, Tokyo, Japan.
  13. Department of Stress Sciences and Psychosomatic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

PMID: 34486816 DOI: 10.1111/jdi.13658

Abstract

AIMS/INTRODUCTION: This systematic review and meta-analysis aimed to investigate the efficacy and safety of acceptance and commitment therapy (ACT) for people with type 2 diabetes mellitus.

MATERIALS AND METHODS: Several electronic databases were examined on 16 January 2021, including PubMed, CENTRAL, PsycINFO, International Clinical Trials Registry Platform and ClinicalTrials.gov. Randomized controlled trials were included to compare ACT with usual treatment for people with type 2 diabetes reported in any language. Primary outcome measures were glycated hemoglobin, self-care ability assessed by the summary of diabetes self-care activities and all adverse events. The secondary outcome measure was acceptance assessed by the acceptance and action diabetes questionnaire.

RESULTS: Of 678 publications initially identified, three trials were included in the meta-analysis. ACT resulted in a reduction in glycated hemoglobin (mean difference -0.62 points lower in the intervention group; 95% confidence interval -1.07 to -0.16; I

CONCLUSIONS: ACT might reduce glycated hemoglobin, and increase self-care ability and acceptance among people with type 2 diabetes.

© 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.

Keywords: Acceptance and commitment therapy; Meta-analysis; Type 2 diabetes

References

  1. Chatterjee S, Khunti K, Davies MJ. Type2 diabetes. Lancet 2017; 389: 2239-2251. - PubMed
  2. Lean MEJ, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 2018; 391: 541-551. - PubMed
  3. Nassar CM, Montero A, Magee MF. Inpatient diabetes education in the real world: an overview of guidelines and delivery models. Curr Diab Rep 2019; 19: 103. - PubMed
  4. Carpenter R, DiChiacchio T, Barker K. Interventions for self-management of type 2 diabetes: an integrative review. Int J Nurs Sci 2019; 6: 70-91. - PubMed
  5. Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. The Lancet 2004; 363: 1589-1597. - PubMed
  6. Westbrook D, Kennerley H, Kirk J. An Introduction to Cognitive Behaviour Therapy: Skills and Application. London: Sage, 2008. - PubMed
  7. Berk KA, Buijks HIM, Verhoeven AJM, et al. Group cognitive behavioural therapy and weight regain after diet in type 2 diabetes: results from the randomised controlled POWER trial. Diabetologia 2018; 61: 790-799. - PubMed
  8. Hermanns N, Schmitt A, Gahr A, et al. The effect of a diabetes-specific cognitive behavioral treatment program (DIAMOS) for patients with diabetes and subclinical depression: results of a randomized controlled trial. Diabetes Care 2015; 38: 551-560. - PubMed
  9. Penckofer SM, Ferrans C, Mumby P, et al. Psychoeducational intervention (SWEEP) for depressed women with diabetes. Ann Behav Med 2012; 44: 192-206. - PubMed
  10. Safren SA, Gonzalez JS, Wexler DJ, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patents with uncontrolled type 2 diabetes. Diabetes Care 2014; 37: 625-633. - PubMed
  11. Chapman A, Liu S, Merkouris S, et al. Psychological interventions for the management of glycemic and psychological outcomes of type 2 diabetes in China: a systematic review and meta-analyses of randomized controlled trials. Front Public Health 2015; 3: 252. - PubMed
  12. Gregg JA, Callaghan GM, Hayes SC, et al. Improving diabetes self-management through acceptance, mindfulness, and values: a randomized controlled trial. J Consult Clin Psychol 2007; 75: 336-343. - PubMed
  13. Page M, Joanne M, Bossuyt P, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71. - PubMed
  14. IDF. Global guideline for type 2 diabetes. Available from: https://www.idf.org/e-library/guidelines/79-global-guideline-for-type-2-diabetes Accessed April 16, 2021. - PubMed
  15. Orem DE. Nursing; Concepts of Practice, 6th edn. Missouri, MO: Mosby, 2001. - PubMed
  16. Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care 2000; 23: 943-950. - PubMed
  17. Hayes SC, Jacobson NS, Follette VM, et al. Acceptance and Change: Content and Context in Psychotherapy. Reno: Context Press, 1994. - PubMed
  18. Higgins JPT, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928. - PubMed
  19. Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev 2019; 10: ED000142. - PubMed
  20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188. - PubMed
  21. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.4. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2020. - PubMed
  22. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011; 64: 383-394. - PubMed
  23. Shayeghian Z, Hassanabadi H, Aguilar-Vafaie ME, et al. A randomized controlled trial of acceptance and commitment therapy for type 2 diabetes management: the moderating role of coping styles. PLoS One 2016; 11: e0166599. - PubMed
  24. Whitehead LC, Crowe MT, Carter JD, et al. A nurse-led education and cognitive behaviour therapy-based intervention among adults with uncontrolled type 2 diabetes: a randomised controlled trial. J Eval Clin Pract 2017; 23: 821-829. - PubMed
  25. Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 2001; 24: 561-587. - PubMed
  26. Uchendu C, Blake H. Effectiveness of cognitive-behavioural therapy on glycaemic control and psychological outcomes in adults with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Diabetes Med 2017; 34: 328-339. - PubMed
  27. Giugliano D, Chiodini P, Maiorino MI, et al. Cardiovascular outcome trials and major cardiovascular events: does glucose matter? A systematic review with meta-analysis. J Endocrinol Investig 2019; 42: 1165-1169. - PubMed
  28. Umpierre D, Ribeiro PA, Kramer CK, et al. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA 2011; 305: 1790-1799. - PubMed
  29. Ose D, Kamradt M, Kiel M, et al. Care management intervention to strengthen self-care of multimorbid patients with type 2 diabetes in a German primary care network: a randomized A controlled trial. PLoS One 2019; 14: e0214056. - PubMed
  30. American Diabetes Association. 5. Facilitating behavior change and well-being to improve health outcomes: standards of medical care in diabetes-2021. Diabetes Care 2021; 44(Suppl 1): S53-S72. - PubMed
  31. Horigan G, Davies M, Findlay-White F, et al. Reasons why patients referred to diabetes education programmes choose not to attend: a systematic review. Diabet Med 2017; 34: 14-26. - PubMed

Publication Types